Merck (MIL:1MRKX) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:1MRKX Merck & Co Inc MIL:1MRKX
62 GF Score
Price €114.94
GF Value €103.54
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Merck FFO per Share?

FFO per Share only applies to REITs.

MIL:1MRKX
62GF Score
Merck & Co Inc MIL:1MRKX
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Merck (MIL:1MRKX) Overvalued in 2026?

Based on GuruFocus' analysis, Merck stock appears to be overvalued. The current stock price of €114.94 is trading 11% above its estimated GF Value™ of €103.54. GuruFocus considers Merck to be Modestly Overvalued.

Key valuation signals for MIL:1MRKX:

  • FFO per Share:
  • GF Value™: €103.54 vs. price of €114.94 (11% above fair value)
  • GF Score™: 62/100 with 8 warning signs

No single metric tells the full story. See the MIL:1MRKX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Merck Business Description

Address 126 East Lincoln Avenue, Rahway, NJ, USA, 07065
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
62GF Score

Get the complete analysis for MIL:1MRKX

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€114.94
Price
€103.54
GF Value